Format

Send to:

Choose Destination
See comment in PubMed Commons below
Med Sci Monit Basic Res. 2014 Jul 30;20:112-7. doi: 10.12659/MSMBR.891168.

Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes.

Author information

  • 1Department of Medical Pharmacology, Psychopharmacology Lab, Medical Faculty, Kocaeli University, Kocaeli, Turkey.
  • 2Department of Medical Pharmacology, Medical Faculty, Dicle University, Diyarbakır, Turkey.
  • 3Department of Endocrinology and Metabolism, Medical Faculty, Kocaeli University, Kocaeli, Turkey.

Abstract

BACKGROUND:

Comorbid neurobehavioral disturbances and type-2 diabetes mellitus (T2DM) warrant immediate research attention. Exenatide, which is a potent and selective agonist for the glucagon-like peptide-1 (GLP-1), is used in the treatment of T2DM. Exenatide displays a multitude of effects in the central nervous system. The aim of this study was to investigate the anxiolytic- and antidepressant-like effects and analgesic effects of exenatide in a type-2 diabetic mouse model.

MATERIAL/METHODS:

Modified elevated plus-maze test for anxiolytic-like, forced swimming test for depression-like behavior and hotplate test for neuropathy were used as behavioral tasks. Behavioral parameters were investigated in a streptozocin--(100 mg/kg, i.p.) and nicotinamide--(240 mg/kg, i.p.) induced type-2 diabetic mouse model. Exenatide (0.1 µg/kg, s.c., twice daily) was administered for 2 weeks. Vehicle (control), diabetic, and exenatide-treated diabetic mice were tested.

RESULTS:

Our results confirm that exenatide exerts anxiolytic- and antidepressant-like effects and might be effective in diabetic neuropathy in a diabetic mouse model.

CONCLUSIONS:

Exenatide may be a good candidate as a treatment option for depression, anxiety, and neuropathy in patients with type-2 diabetes.

PMID:
25076419
[PubMed - indexed for MEDLINE]
PMCID:
PMC4138071
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for International Scientific Literature, Ltd. Icon for PubMed Central
    Loading ...
    Write to the Help Desk